一个没有预放大功能的模块化双CRISPR系统,用于增强病原体检测灵敏度.
Tong Su1,2, Tianhui Wei1, Zichun Wang1
1State Key Laboratory of Flexible Electronics (LoFE) & Jiangsu Key Laboratory of Smart Biomaterials and Theranostic Technology, Institute of Advanced Materials (IAM), Nanjing University of Posts and Telecommunications, 9 Wenyuan Road, Nanjing 210023, China.
Analytical chemistry
|November 25, 2025
概括
一个新的双CRISPR/Cas12a系统与杂交连锁反应 (HCR) 相结合,可实现高度敏感的病原体核酸检测. 这种无预放大方法显著提高了灵敏度,并减少了对各种病原体标的错误阳性.
科学领域:
- 分子生物学分子生物学
- 生物技术是生物技术.
- 诊断 诊断 诊断 诊断
背景情况:
- 克里斯普尔/Cas12a系统为病原体检测提供高特异性,但通常需要预放大,增加复杂性和错误风险.
- 单个CRISPR/Cas12a系统的有限灵敏度需要核酸放大,这带来了诸如交叉污染和错误阳性等挑战.
研究的目的:
- 开发一种通用且高度敏感的病原体核酸检测方法,不需要预放大.
- 提高基于CRISPR/Cas12a的诊断的灵敏度和降低其复杂性.
主要方法:
- 设计了一个模块化双CRISPR/Cas12a系统,包括一个识别模块和一个信号模块.
- 该系统与杂交连锁反应 (HCR) 和DNA纳米结构自组装相结合,用于信号放大.
- 该系统进行了检测,以检测各种病原体核酸,包括非洲猪瘟病毒 (ASFV),严重发烧与血栓塞维症综合征病毒 (SFTSV) 和人类乳头瘤病毒16型 (HPV-16).
主要成果:
- 双CRISPR系统实现了对病原体核酸检测的原子分子 (aM) 灵敏度,超过了传统的单一CRISPR/Cas12a系统超过六个数量级.
- 该系统表现出高灵敏度和特异性,无需进行预放大.
- 该模块化系统证明了多功能性,成功检测出各种病原体目标,并在复杂的样本环境中 (例如,ASFV质量控制) 显示实用性.
结论:
- 开发的无预放大双CRISPR系统在敏感和普遍的病原体核酸检测方面取得了重大进展.
- 这种方法为开发下一代诊断工具提供了一个灵活而强大的平台,其性能提高,复杂性降低.
- 这些发现为加强核酸检测技术在各种应用中开辟了新的途径,包括传染病监测.
相关概念视频
01:28CRISPR/Cas9 Genome Editing
1.6K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.6K
02:53CRISPR and crRNAs
18.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.7K